NCT06372210View on ClinicalTrials.gov

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

July 19, 2023

Study Completion Date

July 19, 2023

Conditions
Mental DisorderSchizophreniaMajor Depressive DisorderBipolar I Disorder
Interventions
DRUG

Placebo IEM tablet

Oral placebo-embedded IEM tablet.

DRUG

Abilify MyCite®

Oral aripiprazole-embedded IEM tablet.

DEVICE

D-Tect Patch

The D-Tect patch is a wearable sensor (WS) capable of detecting the ingestion of the IEM and measuring physiologic parameters. The WS automatically logs and stores the time when the IEM reaches the stomach and transmits the data to a smartphone.

Trial Locations (1)

92845

Research site, Garden Grove

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT06372210 - A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion | Biotech Hunter | Biotech Hunter